Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: April 29, 2024
Reporting Period: As of the close of business on April 29, 2024
Business Context: The Company is an emerging growth company incorporated in Delaware, with principal executive offices in New York, NY. This filing reports on capital structure changes resulting from recent stock issuances and warrant exercises.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on share count updates.
Material Changes
- Share Count Update: As a result of previously disclosed issuances of common stock and the exercise of outstanding warrants, the total number of outstanding shares of common stock increased to 3,117,049 as of April 29, 2024.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on future operations, specific risk factors, contingencies, or unusual items beyond the capitalization update described in Item 8.01.
Investor Verification Checklist
- Verify the exact number of shares issued and warrants exercised to reach the 3,117,049 total outstanding count.
- Review the "previously disclosed" filings referenced in Item 8.01 to understand the terms and pricing of the stock issuances and warrant exercises.
- Confirm the impact of this share count increase on potential dilution for existing shareholders.